-
A farkon watan Maris, Hukumar Kayayyakin Lafiya ta Kasa ta amince da Jaypirca® (pirtobrutinib) don maganin manya da ke fama da cutar sankarar lymphocytic leukemia (CLL) ko ƙananan ƙwayoyin lymphocytic lymphoma (SLL) waɗanda suka sami aƙalla magani ɗaya a baya, gami da maganin Bruton's tyrosin...Kara karantawa»
-
Labari mai daɗi ya fito kwanan nan daga Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kula da Kayayyakin Lafiya ta Ƙasa ta China: an amince da gwajin asibiti na allurar KSD-101, wadda Hensen Bio ta ƙirƙiro,. An yi amfani da shi ne don "ciwon jini da ke da alaƙa da EBV waɗanda ke da...Kara karantawa»
-
Kwanan nan, Hukumar Kayayyakin Lafiya ta Ƙasa ta China (NMPA) ta amince da wani sabon magani na Bireocliclib, wani magani mai suna Aji 1 wanda Xuanzhu Biopharmaceutical ta ƙirƙira daban-daban. Sabon maganin yana da nufin amfani da shi tare da maganin hana aromatase a matsayin maganin farko na endocrine don...Kara karantawa»
-
A ranar 28 ga Fabrairu, 2026, Hukumar Kula da Kayayyakin Lafiya ta Ƙasa (NMPA) ta amince da tallan JMKX001899 sulfate a hukumance don maganin manyan marasa lafiya da ke fama da cutar kansar huhu ta KRAS G12C (NSCLC) wadda aka yi wa lakabi da KRAS G12C wanda aka yi wa kwaskwarima wanda ba shi da wani tasiri a kan ƙananan ƙwayoyin halitta (NSCLC) waɗanda suka sami aƙalla magani ɗaya a baya. JMKX00189...Kara karantawa»
-
A ranar 13 ga Fabrairu, 2026, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Kasa ta kasar Sin ta sanar da cewa an sanya allunan GFH375 a cikin Tsarin Maganin Farko don magance marasa lafiya da ke fama da cutar kansar huhu ta KRAS G12D-mutant non-small cell lung cancer (NSCLC) wadanda suka...Kara karantawa»
-
A ranar 12 ga Fabrairu, 2026, Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kula da Kayayyakin Lafiya ta Kasa ta kasar Sin ta sanar a ranar 4 ga Fabrairu cewa an gabatar da shawarar hada ENHERTU® (trastuzumab deruxtecan) a cikin Shirin Maganin Farko don amfani da shi azaman maganin taimako ga manya marasa lafiya da ke fama da HER2...Kara karantawa»
-
Sashen Duniya na Asibitin Oncology na Yankin Kudu maso Gabashin Beijing yana alfahari da bai wa marasa lafiya na ƙasashen duniya damar samun magungunan ciwon daji na zamani, gami da Maganin Boron Neutron Capture (BNCT) - wani magani mai juyin juya hali wanda ya riga ya canza rayuwa. Tabbacin Rayuwa ta Gaske: Tafiyar Mrs. Wu a 2022...Kara karantawa»
-
A ranar 9 ga Fabrairu, 2026, gidan yanar gizon hukuma na Cibiyar Kimanta Magunguna (CDE) ta Hukumar Kayayyakin Lafiya ta Ƙasa (NMPA) ya sanar da cewa ZL-1310 don allura, wani sabon maganin rigakafi na DLL3 mai niyya ga ƙwayoyin cuta (ADC), ana shirin ba shi Nadin Maganin Farko. A matsayin memba...Kara karantawa»
-
Ga duk wani majiyyaci da ya yi tafiya mai nisa don neman kulawarmu, mun fahimci sosai: abin da kuke kawowa ba wai kawai bayanan lafiya masu rikitarwa ba ne, har ma da aminci da begen dukkan iyalinku. A Sashen Kasa da Kasa na Asibitin Oncology na Yankin Kudu na Beijing, muna shaida irin waɗannan labaran kowace rana—ho...Kara karantawa»
-
Muna fuskantar ƙalubalen maganin cutar kansar hanji ta HER2 mai kama da ta hanji, mun fahimci buƙatarku ta gaggawa don samun ingantattun hanyoyin magani. A yau, muna kawo muku manyan labarai masu ƙarfafa gwiwa daga fannin cutar kansa ta China. **Cikakken Maganin da Aka Samu: SHR-A1811 Ya Nuna Keɓancewa...Kara karantawa»
-
Kwanan nan, Hukumar Kayayyakin Lafiya ta Ƙasa ta China ta amince da haɗin gwiwar maganin Anlotinib Hydrochloride da Penpulimab da Chia Tai Tianqing ta yi don maganin cutar kansar hanta mai ci gaba. Wannan shine karo na goma da aka amince da shi don maganin Anlotinib Hyd...Kara karantawa»
-
Kwanan nan, fannin maganin cutar kansa a China ya cimma wani muhimmin ci gaba. A ranar 7 ga Janairu, 2025, Hukumar Kayayyakin Lafiya ta Kasa ta amince da sabuwar maganin SHR-1701 don amfani a kasuwa. An nuna shi tare da chemotherapy a matsayin magani na farko ga l...Kara karantawa»
Cibiyar likitanci ta haɗin gwiwa ta Asibitin Ciwon Daji na Beijing